Damacell (Gliclazide Tablets) is mainly indicated for non-insulin-dependent (type 2) diabetes mellitus to lower glucose by appearing insulin secretion from pancreatic beta cells. The recommended dose is 1 tablet per day, to be taken orally 20-30 minutes before breakfast. The dose of the drug is adjusted at any time according to the change of blood sugar, and the maximum dose is 4 tablets per day, divided into 2 oral doses. Main side effects hypoglycemic reactions and gastrointestinal reactions include nausea, vomiting, diarrhea, constipation, etc., itching of skin, and elevated transaminases. It can be used in combination with metformin, acarbose, rosiglitazone, daglitazone and other hypoglycemic drugs. type 1 diabetes, diabetic ketoacidosis, severe hepatic and renal insufficiency, lactation, pregnant women, etc. are prohibited.